Chlorambucil-Loaded Graphene-Oxide-Based Nano-Vesicles for Cancer Therapy

In this study, the authors have designed biocompatible nano-vesicles using graphene oxide (GO) for the release of chlorambucil (CHL) drugs targeting cancerous cells. The GO sheets were first sulfonated and conjugated with folic acid (FA) molecules for controlled release and high loading efficiency o...

Full description

Bibliographic Details
Main Authors: Surabhi Kumari, Anuj Nehra, Kshitij Gupta, Anu Puri, Vinay Kumar, Krishna Pal Singh, Mukesh Kumar, Ashutosh Sharma
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/2/649
_version_ 1797618710618308608
author Surabhi Kumari
Anuj Nehra
Kshitij Gupta
Anu Puri
Vinay Kumar
Krishna Pal Singh
Mukesh Kumar
Ashutosh Sharma
author_facet Surabhi Kumari
Anuj Nehra
Kshitij Gupta
Anu Puri
Vinay Kumar
Krishna Pal Singh
Mukesh Kumar
Ashutosh Sharma
author_sort Surabhi Kumari
collection DOAJ
description In this study, the authors have designed biocompatible nano-vesicles using graphene oxide (GO) for the release of chlorambucil (CHL) drugs targeting cancerous cells. The GO sheets were first sulfonated and conjugated with folic acid (FA) molecules for controlled release and high loading efficiency of CHL. The chlorambucil (CHL) drug loading onto the functionalized GO surface was performed through π-π stacking and hydrophobic interactions with the aromatic planes of GO. The drug loading and “in vitro” release from the nano-vesicles at different pH were studied. The average particle size, absorption, and loading efficiency (%) of FA-conjugated GO sheets (CHL-GO) were observed to be 300 nm, 58%, and 77%, respectively. The drug release study at different pH (i.e., 7.4 and 5.5) showed a slight deceleration at pH 7.4 over pH 5.5. The amount of drug released was very small at pH 7.4 in the first hour which progressively increased to 24% after 8 h. The rate of drug release was faster at pH 5.5; initially, 16% to 27% in the first 3 h, and finally it reached 73% after 9 h. These observations indicate that the drug is released more rapidly at acidic pH with a larger amount of drug-loading ability. The rate of drug release from the CHL-loaded GO was 25% and 75% after 24 h. The biotoxicity study in terms of % cell viability of CHL-free and CHL-loaded GO against human cervical adenocarcinoma cell line was found to have lower cytotoxicity of CHL-loaded nano-vesicles (IC<sub>50</sub> = 18 μM) as compared to CHL-free (IC<sub>50</sub> = 8 μM). It is concluded that a high drug-loading efficiency and controlled release with excellent biotoxicity of CHL-GO offers an excellent application in the biomedical field.
first_indexed 2024-03-11T08:17:21Z
format Article
id doaj.art-d789469aa0ee4c0bbafb5d41debf5442
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-11T08:17:21Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-d789469aa0ee4c0bbafb5d41debf54422023-11-16T22:42:45ZengMDPI AGPharmaceutics1999-49232023-02-0115264910.3390/pharmaceutics15020649Chlorambucil-Loaded Graphene-Oxide-Based Nano-Vesicles for Cancer TherapySurabhi Kumari0Anuj Nehra1Kshitij Gupta2Anu Puri3Vinay Kumar4Krishna Pal Singh5Mukesh Kumar6Ashutosh Sharma7Bio-Nanotechnology Research Laboratory, Biophysics Unit, College of Basic Science & Humanities, G.B. Pant University of Agriculture and Technology, Pantnagar 263145, Uttarakhand, IndiaBio-Nanotechnology Research Laboratory, Biophysics Unit, College of Basic Science & Humanities, G.B. Pant University of Agriculture and Technology, Pantnagar 263145, Uttarakhand, IndiaBasic Research Laboratory, Centre for Cancer Research, National Cancer Institute-Frederick, National Institute of Health, Post Office Box. Building 469, Room No. 216A, Frederick, MD 21702-1201, USABasic Research Laboratory, Centre for Cancer Research, National Cancer Institute-Frederick, National Institute of Health, Post Office Box. Building 469, Room No. 216A, Frederick, MD 21702-1201, USADepartment of Physics, CCS Haryana Agricultural University, Hisar 125004, Haryana, IndiaBio-Nanotechnology Research Laboratory, Biophysics Unit, College of Basic Science & Humanities, G.B. Pant University of Agriculture and Technology, Pantnagar 263145, Uttarakhand, IndiaDepartment of Physics, Faculty of Science, Shree Guru Gobind Singh Tricentenary University, Gurgaon 122505, Haryana, IndiaDepartment of Materials Science and Engineering, Ajou University, Suwon 16499, Republic of KoreaIn this study, the authors have designed biocompatible nano-vesicles using graphene oxide (GO) for the release of chlorambucil (CHL) drugs targeting cancerous cells. The GO sheets were first sulfonated and conjugated with folic acid (FA) molecules for controlled release and high loading efficiency of CHL. The chlorambucil (CHL) drug loading onto the functionalized GO surface was performed through π-π stacking and hydrophobic interactions with the aromatic planes of GO. The drug loading and “in vitro” release from the nano-vesicles at different pH were studied. The average particle size, absorption, and loading efficiency (%) of FA-conjugated GO sheets (CHL-GO) were observed to be 300 nm, 58%, and 77%, respectively. The drug release study at different pH (i.e., 7.4 and 5.5) showed a slight deceleration at pH 7.4 over pH 5.5. The amount of drug released was very small at pH 7.4 in the first hour which progressively increased to 24% after 8 h. The rate of drug release was faster at pH 5.5; initially, 16% to 27% in the first 3 h, and finally it reached 73% after 9 h. These observations indicate that the drug is released more rapidly at acidic pH with a larger amount of drug-loading ability. The rate of drug release from the CHL-loaded GO was 25% and 75% after 24 h. The biotoxicity study in terms of % cell viability of CHL-free and CHL-loaded GO against human cervical adenocarcinoma cell line was found to have lower cytotoxicity of CHL-loaded nano-vesicles (IC<sub>50</sub> = 18 μM) as compared to CHL-free (IC<sub>50</sub> = 8 μM). It is concluded that a high drug-loading efficiency and controlled release with excellent biotoxicity of CHL-GO offers an excellent application in the biomedical field.https://www.mdpi.com/1999-4923/15/2/649graphene-oxidechlorambucildrug loadingnano-vesiclescancerin-vitro
spellingShingle Surabhi Kumari
Anuj Nehra
Kshitij Gupta
Anu Puri
Vinay Kumar
Krishna Pal Singh
Mukesh Kumar
Ashutosh Sharma
Chlorambucil-Loaded Graphene-Oxide-Based Nano-Vesicles for Cancer Therapy
Pharmaceutics
graphene-oxide
chlorambucil
drug loading
nano-vesicles
cancer
in-vitro
title Chlorambucil-Loaded Graphene-Oxide-Based Nano-Vesicles for Cancer Therapy
title_full Chlorambucil-Loaded Graphene-Oxide-Based Nano-Vesicles for Cancer Therapy
title_fullStr Chlorambucil-Loaded Graphene-Oxide-Based Nano-Vesicles for Cancer Therapy
title_full_unstemmed Chlorambucil-Loaded Graphene-Oxide-Based Nano-Vesicles for Cancer Therapy
title_short Chlorambucil-Loaded Graphene-Oxide-Based Nano-Vesicles for Cancer Therapy
title_sort chlorambucil loaded graphene oxide based nano vesicles for cancer therapy
topic graphene-oxide
chlorambucil
drug loading
nano-vesicles
cancer
in-vitro
url https://www.mdpi.com/1999-4923/15/2/649
work_keys_str_mv AT surabhikumari chlorambucilloadedgrapheneoxidebasednanovesiclesforcancertherapy
AT anujnehra chlorambucilloadedgrapheneoxidebasednanovesiclesforcancertherapy
AT kshitijgupta chlorambucilloadedgrapheneoxidebasednanovesiclesforcancertherapy
AT anupuri chlorambucilloadedgrapheneoxidebasednanovesiclesforcancertherapy
AT vinaykumar chlorambucilloadedgrapheneoxidebasednanovesiclesforcancertherapy
AT krishnapalsingh chlorambucilloadedgrapheneoxidebasednanovesiclesforcancertherapy
AT mukeshkumar chlorambucilloadedgrapheneoxidebasednanovesiclesforcancertherapy
AT ashutoshsharma chlorambucilloadedgrapheneoxidebasednanovesiclesforcancertherapy